MPLT – maplight therapeutics, inc. (US:NASDAQ)
Stock Stats
News
MapLight Therapeutics, Inc. GAAP EPS of -$2.47 [Seeking Alpha]
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Maplight Therapeutics (MPLT) was downgraded by Wall Street Zen from "
Maplight Therapeutics (MPLT) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $35.00 price target on the stock.
MapLight Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Form S-8 MapLight Therapeutics,
Form 10-K MapLight Therapeutics, For: Dec 31
Form 8-K MapLight Therapeutics, For: Mar 26
Form 4 MapLight Therapeutics, For: Feb 20 Filed by: Malenka Robert C.
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.